ISSN 2424-8592
E-ISSN 2424-9106
Advances in Precision Medicine
Editor-in-Chief: Piccaluga Pier Paolo
Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine. Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.
The authors are required to pay the Article Processing Charge (APC) for publishing with the journal to cover the cost incurred in processing the manuscripts in order to ensure the contents are freely available and to maintain publishing quality. The manuscript processing includes peer review, copy-editing, typesetting, publishing, content depositing and archiving processes. An invoice of APC will be issued after a paper has been accepted, where authors are advised to pay the APC within one week to avoid delay in publication.
In the event that authors insist to withdraw a submission on unethical and unreasonable grounds, a submission withdrawal fee at 30% of the prevailing Article Processing Charge will be levied on the authors. In general, the editors of Bio-Byword Scientific consider the following *unethical and unreasonable reasons* of withdrawing a submission: